Literature DB >> 26191151

Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.

Mariane dos Santos1, Rafael N Bringhenti2, Patrícia G Rodrigues1, Jonathan F do Nascimento1, Sane V Pereira1, Rafael Zancan3, Odirlei A Monticielo4, Andrese A Gasparin4, Waldir P de Castro5, Francisco V Veronese6.   

Abstract

AIM: Glomerular deposition of immune complexes and inflammation induce podocyte injury in lupus nephritis (LN). This study hypothesized that the severity of the histological lesions of LN affects podocyte-associated mRNAs profiles in kidney tissue and in urine.
METHODS: Thirty-three patients with LN were grouped according to the presence of mild mesangial (classes I and II) or moderate-to-severe immune complex deposition, proliferation and/or inflammation (classes III, IV and V) in kidney biopsy. Tissue and urine mRNA of nephrin, podocin, podocalyxin, α-actinin-4, transient receptor potential cation channel 6, and of growth factors VEGF-A and TGF-β1 and the transcription factor FOXP3 were measured using real time polymerase chain reaction. These mRNAs were correlated with histological severity of LN, extent of glomerular immune deposits, and tissue infiltrating cells.
RESULTS: Podocyte-associated mRNAs were inhibited in renal tissue of patients with LN irrespective of histological class when compared to controls. However, significantly higher expression of podocyte mRNAs in urine, including those of growth factors and FOXP3, were found in patients with moderate-to-severe nephritis, mostly in class III and IV proliferative forms. The number of invading CD8+ T cells, B cells and macrophages correlated positively with urine podocyte-associated mRNAs. Urine podocyte mRNAs also correlated with proteinuria.
CONCLUSIONS: Inhibition of podocyte-associated mRNAs in kidney tissue suggests that podocyte injury occurs regardless of class severity of LN. Increased urinary excretion of podocyte mRNAs, mostly in patients with moderate-to-severe lesions, may reflect a greater burden of glomerular damage with detachment of podocytes into the urine.

Entities:  

Keywords:  FOXP3; Systemic lupus erythematosus; lupus nephritis; podocin; podocytes; vascular endothelial growth factor

Mesh:

Substances:

Year:  2015        PMID: 26191151      PMCID: PMC4503023     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  34 in total

1.  Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis?

Authors:  Silvina Gutiérrez; Juan P Petiti; Ana L De Paul; Alicia I Torres; Jorge H Mukdsi
Journal:  Nefrologia       Date:  2012       Impact factor: 2.033

2.  Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies.

Authors:  Patrícia Garcia Rodrigues; Rafael Nazário Bringhenti; Jonathan Frapporti do Nascimento; Gabriel Joelsons; Mariane dos Santos; Sane Pereira; Francisco Veríssimo Veronese
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

3.  Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases.

Authors:  Holger Schmid; Anna Henger; Clemens D Cohen; Karin Frach; Hermann-Josef Gröne; Detlef Schlöndorff; Matthias Kretzler
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

4.  Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.

Authors:  Lionel Couzi; Pierre Merville; Colette Deminière; Jean-François Moreau; Christian Combe; Jean-Luc Pellegrin; Jean-François Viallard; Patrick Blanco
Journal:  Arthritis Rheum       Date:  2007-07

5.  Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis.

Authors:  Y Avihingsanon; P Phumesin; T Benjachat; S Akkasilpa; V Kittikowit; K Praditpornsilpa; J Wongpiyabavorn; S Eiam-Ong; T Hemachudha; K Tungsanga; N Hirankarn
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

Review 6.  Anti-alpha-actinin antibodies: a new marker of lupus nephritis.

Authors:  Yves Renaudineau; Bisram Deocharan; Sandrine Jousse; Eric Renaudineau; Chaim Putterman; Pierre Youinou
Journal:  Autoimmun Rev       Date:  2007-02-22       Impact factor: 9.754

7.  Glomerular podocytopathy in patients with systemic lupus erythematosus.

Authors:  Steven W Kraft; Melvin M Schwartz; Stephen M Korbet; Edmund J Lewis
Journal:  J Am Soc Nephrol       Date:  2004-11-17       Impact factor: 10.121

8.  Increased excretion of urinary podocytes in lupus nephritis.

Authors:  J J Bollain-Y-Goytia; M González-Castañeda; F Torres-Del-Muro; L Daza-Benitez; P Zapata-Benavides; C Rodríguez-Padilla; E Avalos-Díaz; R Herrera-Esparza
Journal:  Indian J Nephrol       Date:  2011-07

9.  The Pathogenesis of Lupus Nephritis.

Authors:  Rosalie M Sterner; Stella P Hartono; Joseph P Grande
Journal:  J Clin Cell Immunol       Date:  2014-04

10.  Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis.

Authors:  Samuel T Waters; Marcia McDuffie; Harini Bagavant; Umesh S Deshmukh; Felicia Gaskin; Chao Jiang; Kenneth S K Tung; Shu Man Fu
Journal:  J Exp Med       Date:  2004-01-12       Impact factor: 14.307

View more
  7 in total

1.  Umbilical Cord Mesenchymal Stem Cells Ameliorate Kidney Injury in MRL/Ipr Mice Through the TGF-β1 Pathway.

Authors:  Chunkai Huang; Mingyao Meng; Shuo Li; Shiyuan Liu; Lin Li; Yanjun Su; Hui Gao; Shan He; Yiyi Zhao; Min Zhang; Zongliu Hou; Wenju Wang; Xiaodan Wang
Journal:  Front Cell Dev Biol       Date:  2022-04-05

2.  Lupus nephritis pathology prediction with clinical indices.

Authors:  Youzhou Tang; Weiru Zhang; Minfeng Zhu; Li Zheng; Lingli Xie; Zhijiang Yao; Hao Zhang; Dongsheng Cao; Ben Lu
Journal:  Sci Rep       Date:  2018-07-06       Impact factor: 4.379

Review 3.  Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6.

Authors:  Giuseppe A Ramirez; Lavinia A Coletto; Clara Sciorati; Enrica P Bozzolo; Paolo Manunta; Patrizia Rovere-Querini; Angelo A Manfredi
Journal:  Cells       Date:  2018-07-04       Impact factor: 6.600

Review 4.  TGF-β1 Signaling: Immune Dynamics of Chronic Kidney Diseases.

Authors:  Philip Chiu-Tsun Tang; Alex Siu-Wing Chan; Cai-Bin Zhang; Cristina Alexandra García Córdoba; Ying-Ying Zhang; Ka-Fai To; Kam-Tong Leung; Hui-Yao Lan; Patrick Ming-Kuen Tang
Journal:  Front Med (Lausanne)       Date:  2021-02-25

5.  CXCL13 Promotes Proliferation of Mesangial Cells by Combination with CXCR5 in SLE.

Authors:  Zhanyun Da; Liuxia Li; Jin Zhu; Zhifeng Gu; Bo You; Ying Shan; Si Shi
Journal:  J Immunol Res       Date:  2016-09-08       Impact factor: 4.818

6.  Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus.

Authors:  Jian Lu; Ze Bo Hu; Pei Pei Chen; Chen Chen Lu; Jia Xiu Zhang; Xue Qi Li; Ben Yin Yuan; Si Jia Huang; Kun Ling Ma
Journal:  BMC Nephrol       Date:  2019-08-05       Impact factor: 2.388

7.  Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies lupus nephritis.

Authors:  Rhea Bhargava; Sylvain Lehoux; Kayaho Maeda; Maria G Tsokos; Suzanne Krishfield; Lena Ellezian; Martin Pollak; Isaac E Stillman; Richard D Cummings; George C Tsokos
Journal:  JCI Insight       Date:  2021-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.